Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasms.

Natural immunity Pub Date : 1998-01-01 DOI:10.1159/000069427
P Lissoni, L Giani, S Zerbini, P Trabattoni, F Rovelli
{"title":"Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasms.","authors":"P Lissoni,&nbsp;L Giani,&nbsp;S Zerbini,&nbsp;P Trabattoni,&nbsp;F Rovelli","doi":"10.1159/000069427","DOIUrl":null,"url":null,"abstract":"<p><p>The possibility of natural cancer therapy has been recently suggested by advances in the knowledge of tumor immunobiology. Either cytokines such as IL-2, or neurohormones, such as the pineal indole melatonin (MLT), may activate anticancer immunity. In addition, immunomodulating substances have also been isolated from plants, particularly from Aloe vera. Preliminary clinical studies had already shown that MLT may induce some benefits in untreatable metastatic solid tumor patients, whereas, for the time being, no clinical trial has been performed with aloe products. We have carried out a clinical study to evaluate whether the concomitant administration of aloe may enhance the therapeutic results of MLT in patients with advanced solid tumors for whom no effective standard anticancer therapies are available. The study included 50 patients suffering from lung cancer, gastrointestinal tract tumors, breast cancer or brain glioblastoma, who were treated with MLT alone (20 mg/day orally in the dark period) or MLT plus A. vera tincture (1 ml twice/day). A partial response (PR) was achieved in 2/24 patients treated with MLT plus aloe and in none of the patients treated with MLT alone. Stable disease (SD) was achieved in 12/24 and in 7/26 patients treated with MLT plus aloe or MLT alone, respectively. Therefore, the percentage of nonprogressing patients (PR + SD) was significantly higher in the group treated with MLT plus aloe than in the MLT gorup (14/24 vs. 7/26, p < 0.05). The percent 1-year survival was significantly higher in patients treated with MLT plus aloe (9/24 vs. 4/26, p < 0.05). Both treatments were well tolerated. This preliminary study would suggest that natural cancer therapy with MLT plus A. vera extracts may produce some therapeutic benefits, at least in terms of stabilization of disease and survival, in patients with advanced solid tumors, for whom no other standard effective therapy is available.</p>","PeriodicalId":77279,"journal":{"name":"Natural immunity","volume":"16 1","pages":"27-33"},"PeriodicalIF":0.0000,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000069427","citationCount":"68","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Natural immunity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000069427","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 68

Abstract

The possibility of natural cancer therapy has been recently suggested by advances in the knowledge of tumor immunobiology. Either cytokines such as IL-2, or neurohormones, such as the pineal indole melatonin (MLT), may activate anticancer immunity. In addition, immunomodulating substances have also been isolated from plants, particularly from Aloe vera. Preliminary clinical studies had already shown that MLT may induce some benefits in untreatable metastatic solid tumor patients, whereas, for the time being, no clinical trial has been performed with aloe products. We have carried out a clinical study to evaluate whether the concomitant administration of aloe may enhance the therapeutic results of MLT in patients with advanced solid tumors for whom no effective standard anticancer therapies are available. The study included 50 patients suffering from lung cancer, gastrointestinal tract tumors, breast cancer or brain glioblastoma, who were treated with MLT alone (20 mg/day orally in the dark period) or MLT plus A. vera tincture (1 ml twice/day). A partial response (PR) was achieved in 2/24 patients treated with MLT plus aloe and in none of the patients treated with MLT alone. Stable disease (SD) was achieved in 12/24 and in 7/26 patients treated with MLT plus aloe or MLT alone, respectively. Therefore, the percentage of nonprogressing patients (PR + SD) was significantly higher in the group treated with MLT plus aloe than in the MLT gorup (14/24 vs. 7/26, p < 0.05). The percent 1-year survival was significantly higher in patients treated with MLT plus aloe (9/24 vs. 4/26, p < 0.05). Both treatments were well tolerated. This preliminary study would suggest that natural cancer therapy with MLT plus A. vera extracts may produce some therapeutic benefits, at least in terms of stabilization of disease and survival, in patients with advanced solid tumors, for whom no other standard effective therapy is available.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
生物疗法与松果体免疫调节激素褪黑激素与褪黑激素加芦荟在无法治疗的晚期实体肿瘤。
自然癌症治疗的可能性最近已提出的进展知识的肿瘤免疫生物学。无论是细胞因子如IL-2,还是神经激素,如松果体吲哚褪黑激素(MLT),都可能激活抗癌免疫。此外,免疫调节物质也已从植物中分离出来,特别是从芦荟中。初步的临床研究已经表明,MLT可能对无法治疗的转移性实体瘤患者有一定的益处,而目前还没有芦荟产品的临床试验。我们进行了一项临床研究,以评估在没有有效的标准抗癌治疗方法的晚期实体瘤患者中,是否同时给予芦荟可以提高MLT的治疗效果。该研究包括50例肺癌、胃肠道肿瘤、乳腺癌或脑胶质母细胞瘤患者,他们分别接受MLT单独治疗(黑暗期口服20mg /天)或MLT加牛皮草酊剂治疗(1ml /天两次)。24例患者中有2例接受MLT +芦荟治疗,而单独接受MLT治疗的患者中没有一例达到部分缓解(PR)。分别在12/24和7/26的患者中,MLT加芦荟或单独MLT治疗达到了疾病稳定(SD)。因此,MLT +芦荟治疗组无进展患者(PR + SD)的百分比明显高于MLT组(14/24比7/26,p < 0.05)。MLT +芦荟治疗的患者1年生存率显著高于对照组(9/24比4/26,p < 0.05)。两种治疗方法均耐受良好。这项初步研究表明,在没有其他标准有效治疗方法的晚期实体瘤患者中,用MLT加芦荟提取物进行自然癌症治疗可能会产生一些治疗益处,至少在疾病稳定和生存方面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Author Index Vol. 16, 1998 Subject Index Vol. 16, 1998 Contents Vol. 16, 1998 Preliminary Pages Session I: Ontogeny and Differentiation of NK and NK-Like Cells
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1